{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:47:34Z","timestamp":1790527654756,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00076","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T09:00:11Z","timestamp":1582016411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria"],"prefix":"10.3389","volume":"11","author":[{"given":"Eman G.","family":"Youssef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondus","family":"Alkhazraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teclegiorgis","family":"Gebremariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannette Y.","family":"Yount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Yeaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Uppuluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1128\/AAC.01464-06","article-title":"Global challenge of multidrug-resistant Acinetobacter baumannii","volume":"51","author":"Perez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1017\/S0950268807009478","article-title":"Acinetobacter infections, a growing threat for critically ill patients","volume":"136","author":"Falagas","year":"2008","journal-title":"Epidemiol Infect"},{"key":"B3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(08)70279-2","article-title":"Current control and treatment of multidrug-resistant Acinetobacter baumannii infections","volume":"8","author":"Karageorgopoulos","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/jac\/dkp428","article-title":"Global spread of carbapenem-resistant Acinetobacter baumannii","volume":"65","author":"Higgins","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3201\/eid1506.081006","article-title":"Extensively drug-resistant Acinetobacter baumannii","volume":"15","author":"Doi","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1086\/650379","article-title":"Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999\u20132006","volume":"31","author":"Hoffmann","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ajic.2009.12.004","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003\u20132008, issued June 2009","volume":"38","author":"Rosenthal","year":"2010","journal-title":"Am J Infect Control"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1086\/648450","article-title":"Epidemiology and impact of imipenem resistance in Acinetobacter baumannii","volume":"30","author":"Lautenbach","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"20248","DOI":"10.2807\/ese.17.33.20248-en","article-title":"Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011","volume":"17","author":"Mammina","year":"2012","journal-title":"Euro Surveill"},{"key":"B10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/JCM.02234-12","article-title":"Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract","volume":"51","author":"Brink","year":"2013","journal-title":"J Clin Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijantimicag.2017.10.011","article-title":"Expansion of KPC-producing Klebsiella pneumoniae with various mgrB-mutations giving rise to colistin-resistance, the role of ISL3 on plasmids","volume":"51","author":"Giordano","year":"2017","journal-title":"Int J Antimicrob Agents."},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-pharmtox-010716-104718","article-title":"Innovative approaches to improve anti-infective vaccine efficacy","volume":"57","author":"Yeaman","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1128\/JB.178.18.5353-5360.1996","article-title":"The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins","volume":"178","author":"Bailey","year":"1996","journal-title":"J Bacteriol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1086\/652407","article-title":"Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target","volume":"201","author":"Luo","year":"2010","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e25909","DOI":"10.1371\/journal.pone.0025909","article-title":"Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis","volume":"6","author":"Luo","year":"2011","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1007056","DOI":"10.1371\/journal.ppat.1007056","article-title":"The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection","volume":"14","author":"Uppuluri","year":"2018","journal-title":"PLoS Pathog"},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.micpath.2014.07.007","article-title":"The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606","volume":"74","author":"Darvish Alipour Astaneh","year":"2014","journal-title":"Microb Pathog"},{"key":"B18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2741\/e801","article-title":"Filamentous hemagglutinin adhesin FhaB limits A. baumannii biofilm formation","volume":"9","author":"Darwish Alipour Astaneh","year":"2017","journal-title":"Front Biosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1128\/IAI.00096-09","article-title":"The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells","volume":"77","author":"Gaddy","year":"2009","journal-title":"Infect Immun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1128\/AAC.02101-13","article-title":"Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii","volume":"58","author":"Smani","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1128\/IAI.06279-11","article-title":"Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice","volume":"80","author":"Gaddy","year":"2012","journal-title":"Infect Immun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1164\/ajrccm.157.2.9705064","article-title":"Ventilator-associated pneumonia caused by potentially drug-resistant bacteria","volume":"157","author":"Trouillet","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"B23","first-page":"763","article-title":"The microbiology of ventilator-associated pneumonia","volume":"50","author":"Park","year":"2005","journal-title":"Respir Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1007\/s00134-009-1582-5","article-title":"Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients","volume":"35","author":"Caricato","year":"2009","journal-title":"Intensive Care Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii, emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/mmy\/myw009","article-title":"Candida spp. airway colonization, a potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia","volume":"54","author":"Tan","year":"2016","journal-title":"Med Mycol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2016_68","article-title":"Evaluation of genetic diversity of Candida spp. and Klebsiella spp. isolated from the denture plaque of COPD patients","volume":"955","author":"Przybylowska","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0130736","DOI":"10.1371\/journal.pone.0130736","article-title":"Sputum bacterial and fungal dynamics during exacerbations of severe COPD","volume":"10","author":"Su","year":"2015","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-0035-1552326","article-title":"The antibiotic resistance crisis, part 1, causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T"},{"key":"B31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fimmu.2014.00463","article-title":"Applying convergent immunity to innovative vaccines targeting Staphylococcus aureus","volume":"5","author":"Yeaman","year":"2014","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"E5555","DOI":"10.1073\/pnas.1415610111","article-title":"Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection","volume":"111","author":"Yeaman","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"30480","DOI":"10.1074\/jbc.M401929200","article-title":"Functional and structural diversity in the Als protein family of Candida albicans","volume":"279","author":"Sheppard","year":"2004","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1128\/IAI.00700-08","article-title":"The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus","volume":"76","author":"Spellberg","year":"2008","journal-title":"Infect Immun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1574-695X.2008.00531.x","article-title":"Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus","volume":"55","author":"Lin","year":"2009","journal-title":"FEMS Immunol Med Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1086\/529204","article-title":"Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity","volume":"197","author":"Spellberg","year":"2008","journal-title":"J Infect Dis"},{"key":"B38","article-title":"Efficacy and immunologic mechanisms of NDV-3 vaccine in a murine model of methicillin-resistant Staphylococcus aureus (MRSA) skin\/skin structure infection (SSSI)","volume-title":"52nd Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Yeaman","year":"2012"},{"key":"B39","article-title":"Efficacy of NDV3 vaccine in a murine model of Staphylococcus aureus skin\/soft tissue infection (SSTI)","volume-title":"Gordon Research Conference on Staphylococcal Diseases.","author":"Yeaman","year":"2011"},{"key":"B40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","article-title":"Klebsiella pneumoniae, going on the offense with a strong defense","volume":"80","author":"Paczosa","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1634\/theoncologist.2017-0167","article-title":"Fixed dosing of monoclonal antibodies in oncology","volume":"22","author":"Hendrikx","year":"2017","journal-title":"Oncologist"},{"key":"B42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent clostridium difficile infection","volume":"376","author":"Wilcox","year":"2017","journal-title":"N England J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.clinthera.2012.11.006","article-title":"GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus, a first-in-humans randomized clinical study","volume":"34","author":"Curtin","year":"2012","journal-title":"Clin Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1167\/iovs.12-10260","article-title":"Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration, a population approach","volume":"54","author":"Xu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/antib7010005","article-title":"Pharmacokinetic and pharmacodynamic considerations for the use of monoclonal antibodies in the treatment of bacterial infections","volume":"7","author":"Wang-Lin","year":"2018","journal-title":"Antibodies"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e00575","DOI":"10.1128\/mBio.00575-13","article-title":"Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus","volume":"4","author":"Falugi","year":"2013","journal-title":"mBio"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/emboj\/21.7.1607","article-title":"IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G","volume":"21","author":"von","year":"2002","journal-title":"EMBO J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/infdis\/151.4.589","article-title":"IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis","volume":"151","author":"Fick","year":"1985","journal-title":"J Infect Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"B50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/cts.12433","article-title":"Animal-to-human dose translation of obiltoxaximab for treatment of inhalational anthrax under the US FDA animal rule","volume":"10","author":"Nagy","year":"2017","journal-title":"Clin Transl Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat Protoc"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER suite, protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/prot.24065","article-title":"Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field","volume":"80","author":"Xu","year":"2012","journal-title":"Proteins"},{"key":"B54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0022-2836(81)90087-5","article-title":"Identification of common molecular subsequences","volume":"147","author":"Smith","year":"1981","journal-title":"J Mol Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0378-1119(88)90330-7","article-title":"CLUSTAL, a package for performing multiple sequence alignment on a microcomputer","volume":"73","author":"Higgins","year":"1988","journal-title":"Gene"},{"key":"B57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam","year":"2014","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1101\/687442","article-title":"Monoclonal IgM antibodies raised against Candida albicans. Hyr1 provide cross-kingdom protection against Gram negative bacteria","author":"Youssef","year":"2019","journal-title":"bioRxiv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T17:45:42Z","timestamp":1665855942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2020.00076"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00076","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/687442","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"article-number":"76"}}